Klinikum Fulda

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Cetuximab Versus Folfiri, Oncology, Clinical Trials +9

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

George Βertsias, Maria G. Tektonidou, Zahir Amoura et al. · Annals of the Rheumatic Diseases · 2012 · 1K citations · Full text

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 538 citations · Full text

Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors

Björn Schumacher, P Pecher, B. U. Specht et al. · Circulation · 1998 · 531 citations

Multi-centre investigation on reference ranges for ROTEM thromboelastometry

Thomas Lang�, Anne Bauters, Siegmund Braun et al. · Blood Coagulation & Fibrinolysis · 2005 · 495 citations

Measurement, Rotem Analysis, Orthopaedic Surgery +19